世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Microbiome Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3758
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、マイクロバイオーム医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロバイオティクス、プレバイオティクス、小分子、生物製剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・マイクロバイオーム医薬品の市場動向
・企業の競争状況、市場シェア
・マイクロバイオーム医薬品の種類別市場規模（プロバイオティクス、プレバイオティクス、小分子、生物製剤、その他）
・マイクロバイオーム医薬品の用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）
・マイクロバイオーム医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・マイクロバイオーム医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・マイクロバイオーム医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・マイクロバイオーム医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・マイクロバイオーム医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Second Genome、Seres Therapeutics、MaaT Pharma、Enterome Bioscience、MicroBiome Therapeutics、Ritter Pharmaceuticals、Rebiotix、OpenBiome）
・結論

Market Analysis and Insights: Global Microbiome Drugs Market
The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microbiome Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microbiome Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microbiome Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microbiome Drugs market.

Global Microbiome Drugs Scope and Market Size
Microbiome Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Probiotics
Prebiotics
Small Molecules
Biological Drugs
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Second Genome
Seres Therapeutics
MaaT Pharma
Enterome Bioscience
MicroBiome Therapeutics
Ritter Pharmaceuticals
Rebiotix
OpenBiome

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Probiotics
1.2.3 Prebiotics
1.2.4 Small Molecules
1.2.5 Biological Drugs
1.2.6 Other
1.3 Market by Application
1.3.1 Global Microbiome Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Microbiome Drugs Market Perspective (2016-2027)
2.2 Microbiome Drugs Growth Trends by Regions
2.2.1 Microbiome Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Drugs Industry Dynamic
2.3.1 Microbiome Drugs Market Trends
2.3.2 Microbiome Drugs Market Drivers
2.3.3 Microbiome Drugs Market Challenges
2.3.4 Microbiome Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Microbiome Drugs Players by Revenue
3.1.1 Global Top Microbiome Drugs Players by Revenue (2016-2021)
3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Drugs Revenue
3.4 Global Microbiome Drugs Market Concentration Ratio
3.4.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2020
3.5 Microbiome Drugs Key Players Head office and Area Served
3.6 Key Players Microbiome Drugs Product Solution and Service
3.7 Date of Enter into Microbiome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Drugs Breakdown Data by Type
4.1 Global Microbiome Drugs Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Drugs Forecasted Market Size by Type (2022-2027)

5 Microbiome Drugs Breakdown Data by Application
5.1 Global Microbiome Drugs Historic Market Size by Application (2016-2021)
5.2 Global Microbiome Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Microbiome Drugs Market Size (2016-2027)
6.2 North America Microbiome Drugs Market Size by Type
6.2.1 North America Microbiome Drugs Market Size by Type (2016-2021)
6.2.2 North America Microbiome Drugs Market Size by Type (2022-2027)
6.2.3 North America Microbiome Drugs Market Size by Type (2016-2027)
6.3 North America Microbiome Drugs Market Size by Application
6.3.1 North America Microbiome Drugs Market Size by Application (2016-2021)
6.3.2 North America Microbiome Drugs Market Size by Application (2022-2027)
6.3.3 North America Microbiome Drugs Market Size by Application (2016-2027)
6.4 North America Microbiome Drugs Market Size by Country
6.4.1 North America Microbiome Drugs Market Size by Country (2016-2021)
6.4.2 North America Microbiome Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Microbiome Drugs Market Size (2016-2027)
7.2 Europe Microbiome Drugs Market Size by Type
7.2.1 Europe Microbiome Drugs Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Drugs Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Drugs Market Size by Type (2016-2027)
7.3 Europe Microbiome Drugs Market Size by Application
7.3.1 Europe Microbiome Drugs Market Size by Application (2016-2021)
7.3.2 Europe Microbiome Drugs Market Size by Application (2022-2027)
7.3.3 Europe Microbiome Drugs Market Size by Application (2016-2027)
7.4 Europe Microbiome Drugs Market Size by Country
7.4.1 Europe Microbiome Drugs Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Microbiome Drugs Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Drugs Market Size by Type
8.2.1 Asia-Pacific Microbiome Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Drugs Market Size by Application
8.3.1 Asia-Pacific Microbiome Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiome Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiome Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiome Drugs Market Size by Region
8.4.1 Asia-Pacific Microbiome Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Microbiome Drugs Market Size (2016-2027)
9.2 Latin America Microbiome Drugs Market Size by Type
9.2.1 Latin America Microbiome Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Drugs Market Size by Type (2016-2027)
9.3 Latin America Microbiome Drugs Market Size by Application
9.3.1 Latin America Microbiome Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Microbiome Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Microbiome Drugs Market Size by Application (2016-2027)
9.4 Latin America Microbiome Drugs Market Size by Country
9.4.1 Latin America Microbiome Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Microbiome Drugs Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Drugs Market Size by Type
10.2.1 Middle East & Africa Microbiome Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Drugs Market Size by Application
10.3.1 Middle East & Africa Microbiome Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiome Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiome Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiome Drugs Market Size by Country
10.4.1 Middle East & Africa Microbiome Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Microbiome Drugs Introduction
11.1.4 Pfizer Revenue in Microbiome Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Second Genome
11.2.1 Second Genome Company Details
11.2.2 Second Genome Business Overview
11.2.3 Second Genome Microbiome Drugs Introduction
11.2.4 Second Genome Revenue in Microbiome Drugs Business (2016-2021)
11.2.5 Second Genome Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Details
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Microbiome Drugs Introduction
11.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2016-2021)
11.3.5 Seres Therapeutics Recent Development
11.4 MaaT Pharma
11.4.1 MaaT Pharma Company Details
11.4.2 MaaT Pharma Business Overview
11.4.3 MaaT Pharma Microbiome Drugs Introduction
11.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2016-2021)
11.4.5 MaaT Pharma Recent Development
11.5 Enterome Bioscience
11.5.1 Enterome Bioscience Company Details
11.5.2 Enterome Bioscience Business Overview
11.5.3 Enterome Bioscience Microbiome Drugs Introduction
11.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2016-2021)
11.5.5 Enterome Bioscience Recent Development
11.6 MicroBiome Therapeutics
11.6.1 MicroBiome Therapeutics Company Details
11.6.2 MicroBiome Therapeutics Business Overview
11.6.3 MicroBiome Therapeutics Microbiome Drugs Introduction
11.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2016-2021)
11.6.5 MicroBiome Therapeutics Recent Development
11.7 Ritter Pharmaceuticals
11.7.1 Ritter Pharmaceuticals Company Details
11.7.2 Ritter Pharmaceuticals Business Overview
11.7.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
11.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2016-2021)
11.7.5 Ritter Pharmaceuticals Recent Development
11.8 Rebiotix
11.8.1 Rebiotix Company Details
11.8.2 Rebiotix Business Overview
11.8.3 Rebiotix Microbiome Drugs Introduction
11.8.4 Rebiotix Revenue in Microbiome Drugs Business (2016-2021)
11.8.5 Rebiotix Recent Development
11.9 OpenBiome
11.9.1 OpenBiome Company Details
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Microbiome Drugs Introduction
11.9.4 OpenBiome Revenue in Microbiome Drugs Business (2016-2021)
11.9.5 OpenBiome Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Microbiome Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Probiotics
Table 3. Key Players of Prebiotics
Table 4. Key Players of Small Molecules
Table 5. Key Players of Biological Drugs
Table 6. Key Players of Other
Table 7. Global Microbiome Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Microbiome Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Microbiome Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Microbiome Drugs Market Share by Regions (2016-2021)
Table 11. Global Microbiome Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Microbiome Drugs Market Share by Regions (2022-2027)
Table 13. Microbiome Drugs Market Trends
Table 14. Microbiome Drugs Market Drivers
Table 15. Microbiome Drugs Market Challenges
Table 16. Microbiome Drugs Market Restraints
Table 17. Global Microbiome Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Microbiome Drugs Market Share by Players (2016-2021)
Table 19. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2020)
Table 20. Ranking of Global Top Microbiome Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Microbiome Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Microbiome Drugs Product Solution and Service
Table 24. Date of Enter into Microbiome Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Microbiome Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Microbiome Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Microbiome Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Microbiome Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Microbiome Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Microbiome Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Microbiome Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Microbiome Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Microbiome Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Microbiome Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Microbiome Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Microbiome Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Microbiome Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Microbiome Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Microbiome Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Microbiome Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Microbiome Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Microbiome Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Microbiome Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Microbiome Drugs Product
Table 67. Pfizer Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Second Genome Company Details
Table 70. Second Genome Business Overview
Table 71. Second Genome Microbiome Drugs Product
Table 72. Second Genome Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 73. Second Genome Recent Development
Table 74. Seres Therapeutics Company Details
Table 75. Seres Therapeutics Business Overview
Table 76. Seres Therapeutics Microbiome Drugs Product
Table 77. Seres Therapeutics Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 78. Seres Therapeutics Recent Development
Table 79. MaaT Pharma Company Details
Table 80. MaaT Pharma Business Overview
Table 81. MaaT Pharma Microbiome Drugs Product
Table 82. MaaT Pharma Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 83. MaaT Pharma Recent Development
Table 84. Enterome Bioscience Company Details
Table 85. Enterome Bioscience Business Overview
Table 86. Enterome Bioscience Microbiome Drugs Product
Table 87. Enterome Bioscience Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 88. Enterome Bioscience Recent Development
Table 89. MicroBiome Therapeutics Company Details
Table 90. MicroBiome Therapeutics Business Overview
Table 91. MicroBiome Therapeutics Microbiome Drugs Product
Table 92. MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 93. MicroBiome Therapeutics Recent Development
Table 94. Ritter Pharmaceuticals Company Details
Table 95. Ritter Pharmaceuticals Business Overview
Table 96. Ritter Pharmaceuticals Microbiome Drugs Product
Table 97. Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 98. Ritter Pharmaceuticals Recent Development
Table 99. Rebiotix Company Details
Table 100. Rebiotix Business Overview
Table 101. Rebiotix Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 102. Rebiotix Recent Development
Table 103. OpenBiome Company Details
Table 104. OpenBiome Business Overview
Table 105. OpenBiome Microbiome Drugs Product
Table 106. OpenBiome Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 107. OpenBiome Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Drugs Market Share by Type: 2020 VS 2027
Figure 2. Probiotics Features
Figure 3. Prebiotics Features
Figure 4. Small Molecules Features
Figure 5. Biological Drugs Features
Figure 6. Other Features
Figure 7. Global Microbiome Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Other Case Studies
Figure 12. Microbiome Drugs Report Years Considered
Figure 13. Global Microbiome Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Microbiome Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Microbiome Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Microbiome Drugs Market Share by Regions (2022-2027)
Figure 17. Global Microbiome Drugs Market Share by Players in 2020
Figure 18. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Microbiome Drugs Revenue in 2020
Figure 20. Global Microbiome Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Microbiome Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Microbiome Drugs Market Share by Type (2016-2027)
Figure 24. North America Microbiome Drugs Market Share by Application (2016-2027)
Figure 25. North America Microbiome Drugs Market Share by Country (2016-2027)
Figure 26. United States Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Microbiome Drugs Market Share by Type (2016-2027)
Figure 30. Europe Microbiome Drugs Market Share by Application (2016-2027)
Figure 31. Europe Microbiome Drugs Market Share by Country (2016-2027)
Figure 32. Germany Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Microbiome Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Microbiome Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Microbiome Drugs Market Share by Region (2016-2027)
Figure 42. China Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Microbiome Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Microbiome Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Microbiome Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Microbiome Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Microbiome Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Microbiome Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 62. Second Genome Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 63. Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 64. MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 65. Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 66. MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 67. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 68. Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 69. OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2951 2021年4月 95Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療薬・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療、診断）、用途別市場規模（臨床研究所、病院、手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2955 2021年4月 99Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム治療薬）、用途別市場規模（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他）...

世界のヒトマイクロバイオーム市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Market Size, Status and Forecast 2021-2027
QYR2104Z2952 2021年4月 133Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオームのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消化管ヒトマイクロバイオーム、泌尿生殖器ヒトマイクロバイオーム、その他）、用途別市場規模（治療、診断）、主要地域別市場規模（北米、...

世界のマイクロバイオームシーケンスサービス市場規模・現状・予測（2021年-2027年）

Global Microbiome Sequencing Services Market Size, Status and Forecast 2021-2027
QYR2104Z3759 2021年4月 91Pages
QYResearch社発行の本調査資料では、マイクロバイオームシーケンスサービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成シーケンシング、ライゲーションシーケンシング、サンガーシーケンシング）、用途別市場規模（製薬、バイオテクノロジー...

世界のマイクロバイオームシーケンスサービス市場規模・現状・予測（2021年-2027年）

世界のマイクロバイオーム治療市場規模・現状・予測（2021年-2027年）

Global Microbiome Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3760 2021年4月 130Pages
QYResearch社発行の本調査資料では、マイクロバイオーム治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アッパーGIT、ローワーGIT）、用途別市場規模（炎症性腸疾患（IBD）、希少疾病用医薬品、免疫腫瘍、その他）、主要地域別市場規模...

世界のヒトマイクロバイオームシーケンシング市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Sequencing Market Size, Status and Forecast 2021-2027
QYR2104Z2953 2021年4月 127Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオームシーケンシングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング、従来型シーケンシング技術、その他）、用途別市場規模（ゲノム解析、メタボローム解析、トランスクリ...

世界のヒトマイクロバイオームシーケンシング技術市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Sequencing Technology Market Size, Status and Forecast 2021-2027
QYR2104Z2954 2021年4月 127Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオームシーケンシング技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来型シーケンシング技術、次世代シーケンシング、第3世代シーケンシング）、用途別市場規模（研究・学術機関、製薬・...

世界のイロプロスト薬市場規模・現状・予測（2021年-2027年）

Global Iloprost Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z3033 2021年4月 93Pages
QYResearch社発行の本調査資料では、イロプロスト薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸入、静脈内）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南...

世界の不妊症治療薬市場規模・現状・予測（2021年-2027年）

Global Infertility Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z3152 2021年4月 94Pages
QYResearch社発行の本調査資料では、不妊症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゴナドトロピン、抗エストロゲン）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…
世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…
世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
世界のOTC外用薬市場規模・現状・予測（2021年-2027年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
世界の抗酸菌症治療薬市場規模・現状・予測（2021年-2027年） Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively. The hospital pharmacies segment dominated th…